|
|
- 2018
Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis PainDOI: 10.1007/s40122-018-0095-8 Keywords: Chronic pain, Chronic pain control, Low back pain, Osteoarthritis pain, Severe chronic pain, Tapentadol Abstract: Molecular structure of tapentadol, described as an MOR-NRI agent (mu-opioid receptor agonist and norepinephrine reuptake inhibitor
|
